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Abstract  Chromosome  22q11.2  deletion  syndrome,  or  DiGeorge  syndrome,  or  velocardiofacial
syndrome,  is  one  of  the  most  common  multiple  anomaly  syndromes  in  humans.  This  syndrome  is
commonly caused  by  a  microdelection  from  chromosome  22  at  band  q11.2.  Although  this  genetic
disorder  may  reﬂect  several  clinical  abnormalities  and  different  degrees  of  organ  commitment,
the clinical  features  that  have  driven  the  greatest  amount  of  attention  are  behavioral  and
developmental  features,  because  individuals  with  22q11.2  deletion  syndrome  have  a  30-fold
risk of  developing  schizophrenia.  There  are  differing  opinions  about  the  cognitive  development,
and commonly  a  cognitive  decline  rather  than  an  early  onset  intellectual  disability  has  been
observed. We  report  a  case  of  22q11.2  deletion  syndrome  with  both  early  assessment  of  mild
intellectual  disabilities  and  tetralogy  of  Fallot  as  the  only  physic  manifestation.
© 2015  Sociedad  Chilena  de  Pediatría.  Published  by  Elsevier  España,  S.L.U.  This  is  an  open  access
article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Resumen  El  síndrome  del  cromosoma  22q11.2,  también  conocido  como  supresión  o  síndrome
de DiGeorge  o  síndrome  velocardiofacial,  es  uno  de  los  síndromes  más  comunes  de  anomalías
múltiples en  los  seres  humanos.  Este  síndrome  es  comúnmente  causado  por  una  microdeleción
del cromosoma  22  en  q11.2  banda.  Aunque  este  trastorno  genético  muestra  varias  anomalías
clínicas y  diferentes  grados  de  compromiso  orgánico,  las  características  clínicas  que  han  atraído Please cite this article as: Cascella M, Muzio M. R. Inicio temprano de discapacidad intelectual en el Síndrome de deleción del cromosoma
22q11.2. Rev Chil Pediatr. 2015;86:282.
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la  mayor  atención  son  el  comportamiento  y  el  desarrollo,  porque  las  personas  con  síndrome  de
deleción 22q11.2  tienen  un  riesgo  30  veces  mayor  de  desarrollar  esquizofrenia.  Hay  diferentes
opiniones  sobre  el  desarrollo  cognitivo,  y  comúnmente  se  se  ha  observado  un  deterioro  cognitivo
en lugar  de  un  inicio  temprano  de  discapacidad  intelectual.  Presentamos  un  caso  de  síndrome
de deleción  22q11.2  tanto  con  la  evaluación  temprana  de  discapacidades  intelectuales  leves
como con  la  tetralogía  de  Fallot  como  única  manifestación  física.
© 2015  Sociedad  Chilena  de  Pediatría.  Publicado  por  Elsevier  España,  S.L.U.  Este  es  un
artículo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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hromosome  22q11.2  deletion  syndrome  (22q11DS),  previ-
usly  also  known  as  DiGeorge  syndrome  or  velocardiofacial
yndrome,  is  a  complex  genomic  disorder  caused  in  most
ases  by  a  hemizygous  3-megabase  microdeletion  from
hromosome  22  at  band  q11.2.  The  22q11DS  can  shows  sev-
ral  clinical  abnormalities  and  different  degrees  of  organ
ommitment.1 More  than  180  clinical  features,  have  been
escribed,  not  only  physical  but  behavioral  and  psychiatric,
oo.2 Children  and  adults  with  22q11DS  have  high  rates
f  behavioral,  psychiatric,  and  communication  disorders.
n  children,  these  include  attention  deﬁcit/hyperactivity
isorder,  anxiety,  and  affective  disorders.  Adults  have  a
igh  rate  of  psychotic  disorders,  particularly  schizophrenia.3
opulation  22q11DS  usually  have  a  below-borderline  nor-
al  intelligence  quotient  (IQ),  with  most  individuals  having
igher  scores  in  the  verbal  than  the  nonverbal  domains.
ome  are  able  to  attend  normal  schools,  while  others  are
omeschooled  or  in  special  classes.  The  severity  of  hypocal-
emia  early  in  childhood  is  associated  with  autism-like
ehavioral  difﬁculties.4 The  objective  of  this  study  was  to
eport  a  case  of  22q11DS  with  both  early  assessment  of  mild
ntellectual  disabilities  (ID)  and  tetralogy  of  Fallot  (TOF)  as
nly  clinical  manifestation.
ase report
 13  years  old  Caucasian  male  is  followed  by  our  infantile
europsychiatry  team,  since  he  was  3  years  old.  He  came
o  our  observation  for  both  severely  expressive  language
eﬁcits  and  motor  dysfunction.  The  personal  anamnesis
howed  the  intrauterine  diagnosis  of  TOF,  however  at  birth
here  were  no  perinatal  asphyxia  (APGAR  score  was  8  at
 min  and  9  at  5  min).  He  was  born  with  labor  at  term
ia  spontaneous  vaginal  delivery,  weighing  3017  g.  TOF  was
anaged  with  a  two-stage  repair  strategy  with  an  initial  pal-
iation  (systemic-to-pulmonary  shunt  operation  at  the  age
f  2  months)  followed  by  later  repair  (transanular  repair  at
he  age  of  18  months).  Family  history  was  non-contributory.
ecause  of  the  presence  of  this  heart  defect,  testing  for
he  22q11DS  was  performed.  A  22q11.2  FISH  genetic  anal-
sis  with  LSI  DiGeorge  N25(D22S75)  and  LSI  DiGeorge/VCFS
Vysis)  probes  showed  a  microdeletion  from  chromosome  22
t  band  q11.2.  At  the  age  of  4  years  old  the  child  showed
ifﬁculties  of  acquiring  vocabulary  and  formulating  a  spoken
anguage.  His  motor  dysfunction  consisted  in  performance  of
otor  coordination,  signiﬁcantly  below  the  expected  level
i
p
m
cor  his  age  (developmental  coordination  disorder).  At  ﬁrst,
ull-scale  IQ  was  assessed  by  using  Wechsler  Preschool  and
rimary  Scale  of  Intelligence  (WPPSI).  This  test  showed  an
Q  of  54,  suggestive  for  a  mild  ID,  conﬁrmed  with  both  the
aven  Progressive  Matrices  at  the  age  of  7  years  old,  and
he  Wechsler  Intelligence  Scale  for  Children  (WISC-R  =  51)  at
he  age  of  10  years  old.  The  last  IQ  test  administered  (WISC
V  =  52  at  the  age  of  12  years  old),  further  conﬁrmed  the
egree  of  the  intellectual  development  disorder  (ICD-11),
ith  deﬁcits  in  sustained  attention,  working  memory,  execu-
ive  function,  verbal  learning,  and  visual--spatial  processing.
he  parents  had  a  good  educational  level  (high  school)
howing  a normal  IQ  (WAIS-III).  TOF  was  the  only  physic
anifestation  of  22q11DS.  There  were  no  other  features
uch  as  facial  dysmorphisms  and  immunodeﬁciency,  as  well
s  hypocalcemia,  gastroesophageal  reﬂux  and  atopy.  Fur-
hermore,  the  nasopharyngoscopy  did  not  show  any  palate
nomalies.  The  child  received  educational  services  with  psy-
homotor  education  until  he  was  7  years  old  and  logopedy
ntil  the  age  of  10  years  old;  furthermore  at  this  age  he
tarted  a program  of  occupational  therapy.
iscussion
hromosome  22q11DS  is  one  of  the  most  common  mul-
iple  anomaly  syndromes  in  humans  with  a  population
revalence  ranging  from  approximately  12,000  to  16,000.5
lthough  a  large  number  of  clinical  features  have  been
eported  in  association  with  22q11DS,  the  anomalies  that
ave  attracted  the  greatest  amount  of  attention  are  the
ehavioral  and  developmental.  While  Shprintzen  et  al.6
escribed  at  ﬁrst  psychiatric  disorders  in  22q11DS,  a  lot
f  researchers  studied  22q11.2  resided  genes,  inﬂuenc-
ng  psychiatric  phenotypes.7,8 According  to  Shprintzen  it
s  not  yet  clear  what  biologic  basis  of  mental  illness  in
2q11DS,  however  the  syndrome  is  an  clinical  model  for
nderstanding  psychiatric  disorders,  especially  psychosis,  in
umans.9 People  with  22q11DS  have  a  30-fold  risk  of  devel-
ping  schizophrenia,  suggesting  that  the  22q11.2  deletion
an  be  considered  the  highest  known  genetic  risk  factor
or  schizophrenia.10,11 The  neurocognitive  proﬁle  is  also
ighly  variable,  both  between  individuals  and  during  the
ourse  of  development.12 It  is  well  known  that  schizophre-
ia  phenotype  includes  a  cognitive  deﬁcit  and  a  decline
n  academic  performance  preceding  the  ﬁrst  episode  of
sychosis.12 Duijff  et  al.13 studying  the  cognitive  develop-
ent  in  children  with  22q11DS,  suggested  that  the  ﬁnding  of
ognitive  decline  can  be  only  partly  explained  as  the  result
letio
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of  ‘growing  into  deﬁcit’;  indeed  in  their  study  about  a  third
of  children  with  the  syndrome  showed  an  absolute  loss  of
cognitive  faculties  previously  acquired.13 Recently,  results
from  the  International  Consortium  on  Brain  and  Behavior  in
22q11DS  have  been  published.14 This  study  conﬁrms  previ-
ous  ﬁndings  that  this  syndrome  is  one  of  the  most  important
risk  factors  for  psychosis,  because  the  authors  report  an
high  prevalence  of  schizophrenia  spectrum  disorders;  indeed
attention  deﬁcit  hyperactivity  disorder  (ADHD)  as  well  as
mood  and  anxiety  disorders  were  also  prevalent.  Severe
cognitive  impairment  was  associated  with  schizophrenia
spectrum  disorders,14 however  this  result  can  be  detected  in
both  22q11DS  patients  and  general  population.  The  associa-
tion  of  developmental  delays  (particularly  in  language)  are
very  common  in  patients  with  22q11DS.  While  our  patient
did  not  present  any  psychiatric  disorders,  nevertheless  he
was  last  assessed  at  age  12  years,  so  subsequent  develop-
ment  of  psychosis  cannot  be  excluded;  indeed  according  to
Vorstman  et  al.,15 the  early  cognitive  decline  is  a  strong
indicator  of  the  risk  of  developing  psychosis  and  our  com-
mitment  will  be  to  follow  the  patient  in  years.  The  real
peculiarity  was  the  early  ID  rather  than  a  more  speciﬁc
cognitive  decline.  A  lot  of  studies  demonstrated  that  cog-
nitive  impairments  are  common  in  individuals  with  22q11DS
with  a  mean  IQ  of  75,16--18 suggesting  that  other  factors  con-
tribute  to  adaptive  functioning  in  this  population,  such  as
poorer  socialization  and  communication  skills.19 Our  patient
showed  a  cognitive  deﬁcit  with  both  early  onset  and  IQ
less  than  commonly  observed  in  22q11DS.  Tarsitano  et  al.20
described  a  case  of  22q11DS  associated  with  ID,  however
in  their  case  there  were  evident  dysmorphic  features  and
an  additional  genomic  disorder  (duplication  in  8q22.1).  Dys-
morphic  facial  features  with  attention  disorder  and  learning
difﬁculties  were  present  in  two  cases  described  in  literature,
however  in  this  double  report  there  were  not  informa-
tion  about  the  degree  of  intellectual  development  disorder
assessed  with  any  full-scale  IQ.21 In  our  case  there  were  not
neonatal  hypocalcemia  and/or  seizures.  This  is  another  par-
ticularity  of  our  case,  because  according  to  Cheung  et  al.22
both  two  conditions  are  associated  with  the  severity  of  ID.
The  results  of  several  studies  conﬁrm  that  palate  anomalies
are  very  common  in  this  syndrome23,24;  so  these  features
require  recognition  and  treatment  and  may  impact  cog-
nitive  evaluation.  Although  the  palate  anomalies  such  as
submucous  cleft  palate  and  velopharyngeal  insufﬁciency
are  common,  and  these  conditions  if  underdiagnosed  can
contribute  to  speech  and  language  delays,  however  in  our
patient  the  nasopharyngoscopy  did  not  show  any  sign  of
palate  anomalies.
Conclusion
Chromosome  22q11DS  is  relatively  common  and  this  diag-
nosis  should  be  considered  in  patients  who  have  TOF
features  accompanied  by  psychiatric  and  behavioral  dis-
orders.  It  is  important  that  we  remain  open  to  the  more
subtle  manifestations  of  22q11DS  because  this  syndrome
remains  undiagnosed  in  many  children.  Our  case  is  a  par-
ticular  report  of  22q11DS  for  the  early  mild  intellectual
disabilities  with  an  early  ID  rather  than  a  more  speciﬁc
cognitive  decline.13 The  guidelines  also  state  clearly  thatn  syndrome  285
ysmorphic  features  can  be  subtle  in  some  children  with
2q11DS.25 However,  to  our  knowledge,  the  combination
f  early  onset  mild  ID  with  no  other  features  such  as
acial  dysmorphisms,  palate  anomalies,  immunodeﬁciency,
ypocalcemia,  gastroesophageal  reﬂux  and  atopy  is  an
nusual  clinical  manifestation  of  22q11DS.
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